Summary Judgment on Kickback, False Claims, Off-Label Allegations

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Court Grants Summary Judgment to Allergan on Kickback-Based False Claims, Off-Label Allegations

Dennis Tosh

March 12, 2025 at 05:59 PM EST

A federal district court in Texas has granted summary judgment in favor of a drug manufacturer on a whistleblower’s false claims, kickback and off-label promotion allegations that had previously survived motions to dismiss (United States ex rel. Hearrell v. Allergan, Inc., No. 2:21-cv-00204-JRG, 2025 U.S. Dist. LEXIS 37033, 2025 WL 675445 (E.D. Tex. March 3, 2025)). In a suit... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Court Grants Summary Judgment to Allergan on Kickback-Based False Claims, Off-Label Allegations

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT